The Association for Research in Vision and Ophthalmology (ARVO) Foundation has announced Maria Vittoria Cicinelli, MD, Denise ...
Additionally, Unity Biotechnology also announced 3 Yehia Hashad, MD, executive vice president of research and development and ...
The award honors Ludwig von Sallmann, MD, a “distinguished international ophthalmologist and ophthalmic investigator whose ...
A total of 43 patients who recovered from the SARS-CoV-2 infection with mild pneumonia were included along with 45 healthy ...
Insights shed light on what the approval means for providers and their patients affected by this neurodegenerative retinal ...
D-150 is a potential backbone therapy that is designed to provide multi-year sustained delivery of anti-VEGF (aflibercept and ...
The FDA has set a PDUFA target action date of October 23, 2025, for the low-dose atropine formulation.
Ocular surface discomfort can be problematic after cataract surgery. Italian researchers tested the use of cyclosporine A 0.1 ...
Urcosmid is a lipid conjugated chemerin peptide agonist of the ChemR23 G-protein coupled receptor, typically found on immune ...
RPESC-RPE-4W is a proprietary retinal pigment epithelium cell therapy for patients with dry age-related macular degeneration.
Additionally, the prognosis of macular edema may help clinicians evaluate renal function, investigators reported ...